Is Your Patient Immunocompromised?

Director of the Transplant & Cellular Therapy Center at Roswell Park Comprehensive Cancer Center, Phillip McCarthy, MD, discusses protocols in place to ensure the safety of our most vulnerable patient population. Dr. McCarthy also reviews case studies and preliminary outcomes of COVID-19 positive patients.

Experts & Moderators

Philip McCarthy, MD
Hematologic Oncology
Professor of Oncology and Internal Medicine
Director, Transplant & Cellular Therapy Center, Department of Medicine
Rebecca Vogt
Rebecca Vogt
Media Relations Specialist

Created by

Roswell Park Comprehensive Cancer Center